Aspirin protects endothelial cells from oxidative stress - possible synergism with vitamin E

被引:86
作者
Podhaisky, HP [1 ]
Abate, A [1 ]
Polte, T [1 ]
Oberle, S [1 ]
Schroder, H [1 ]
机构
[1] UNIV HALLE WITTENBERG,SCH PHARM,DEPT PHARMACOL & TOXICOL,D-06099 HALLE,SAALE,GERMANY
关键词
aspirin; vitamin E; D-alpha-tocopherol acetate; endothelial cells; cytoprotection; antioxidant;
D O I
10.1016/S0014-5793(97)01307-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A 24-h incubation with hydrogen peroxide (0.65 mM) markedly reduced viability of cultured endothelial cells, Preincubation with aspirin (3-30 mu M) protected endothelial cells from hydrogen peroxide-induced toxicity and increased viability in a concentration-dependent fashion by up to 64% of control, A similar protection was observed with D-alpha-tocopherol acetate (vitamin E, 3-30 mu-M) The cytoprotective effects of aspirin and vitamin E against hydrogen peroxide were overadditive suggesting different mechanisms of antioxidant action, In agreement with this, cytotoxicity induced by iron, the main catalyst of oxygen radical formation, was substantially reduced by aspirin but not vitamin E. These results show that aspirin protects endothelial cells from oxidative stress possibly via binding or chelation of free cytosolic iron, Moreover, a combination of aspirin and vitamin E might be useful for the prevention of endothelial injury in cardiovascular disease, e.g. during atherogenesis. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:349 / 351
页数:3
相关论文
共 20 条
[1]   THE IRON-BINDING AND HYDROXYL RADICAL SCAVENGING ACTION OF ANTI-INFLAMMATORY DRUGS [J].
ARUOMA, OI ;
HALLIWELL, B .
XENOBIOTICA, 1988, 18 (04) :459-470
[2]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[3]   HYDROGEN-PEROXIDE ALTERS THE PHYSICAL STATE AND FUNCTION OF THE PLASMA-MEMBRANE OF PULMONARY-ARTERY ENDOTHELIAL-CELLS [J].
BLOCK, ER .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 146 (03) :362-369
[4]   SUPPRESSION OF THROMBOXANE-A2 BUT NOT OF SYSTEMIC PROSTACYCLIN BY CONTROLLED-RELEASE ASPIRIN [J].
CLARKE, RJ ;
MAYO, G ;
PRICE, P ;
FITZGERALD, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) :1137-1141
[5]   COMPARISON OF INVITRO-CELL CYTO-TOXIC ASSAYS FOR TUMOR NECROSIS FACTOR [J].
FLICK, DA ;
GIFFORD, GE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 68 (1-2) :167-175
[6]   The case for low-dose aspirin for the prevention of myocardial infarction: But how low is low? [J].
Forster, W ;
Parratt, JR .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 10 (06) :727-734
[7]   ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE [J].
FUSTER, V ;
DYKEN, ML ;
VOKONAS, PS ;
HENNEKENS, C .
CIRCULATION, 1993, 87 (02) :659-675
[8]  
Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
[9]   THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].
HAMBERG, M ;
SVENSSON, J ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998
[10]  
OBERLE S, 1997, IN PRESS NITRIC OXID